Forkhead box F1 functions as a novel prognostic biomarker and induces caspase‑dependent apoptosis in bladder cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8610
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2023 AND VI 50 AND IP 3
Results: 12
1
2
SPAG5, the upstream protein of Wnt and the target of curcumin, inhibits hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8609
- By:
- Publication type:
- Article
3
[Corrigendum] Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8608
- By:
- Publication type:
- Article
4
Copper (II) complex of salicylate phenanthroline induces the apoptosis of colorectal cancer cells, including oxaliplatin‑resistant cells.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8607
- By:
- Publication type:
- Article
5
Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8606
- By:
- Publication type:
- Article
6
[Retracted] Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8605
- By:
- Publication type:
- Article
7
Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via ATM‑ERK cascade in adrenocortical carcinoma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8604
- By:
- Publication type:
- Article
8
Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8603
- By:
- Publication type:
- Article
9
[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8602
- By:
- Publication type:
- Article
10
Upregulation of integrin‑linked kinase enhances tumor progression in gemcitabine‑resistant pancreatic cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8601
- By:
- Publication type:
- Article
11
Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8600
- By:
- Publication type:
- Article
12
Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain‑of‑function and targeting therapy (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8599
- By:
- Publication type:
- Article